Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Neoplasm Metastasis 10Lung Neoplasms 9Carcinoma, Medullary 9Neoplasms 6Thyroid Neoplasms 5Glioma 5Glioblastoma 5Gliosarcoma 4Colorectal Neoplasms 4Brain Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Familial medullary thyroid carcinoma 2Disease Progression 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Biliary Tract Neoplasms 2Waldenstrom Macroglobulinemia 1Urethral Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1

Interventions

Cisplatin 33Radiotherapy 23Cetuximab 18Paclitaxel 14Docetaxel 14pembrolizumab 13Carboplatin 12Fluorouracil 10Radiotherapy, Intensity-Modulated 8Nivolumab 8Drug Therapy 7Erlotinib Hydrochloride 6Panitumumab 5dacomitinib 4Radiation 4Methotrexate 4Esophagectomy 4130-nm albumin-bound paclitaxel 4durvalumab 3ON 01910 3Leucovorin 3Gemcitabine 3Chemoradiotherapy 3vandetanib 2palbociclib 2osimertinib 2nedaplatin 2fludarabine 2cabazitaxel 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Squamous Cell × vandetanib × Clear all
NCT00404924 2016-09-30

ZD6474 (ZACTIMAâ„¢) Phase III Study in EGFR Failures

Sanofi

Phase 3 Completed
1,140 enrolled 12 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00450138 2016-08-29

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Sanofi

Phase 1 Completed
48 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡